Pharmacoepigenetics in heart failure

Curr Heart Fail Rep. 2010 Jun;7(2):83-90. doi: 10.1007/s11897-010-0011-y.

Abstract

Epigenetics studies inheritable changes of genes and gene expression that do not concern DNA nucleotide variation. Such modifications include DNA methylation, several forms of histone modification, and microRNAs. From recent studies, we know not only that genetic changes account for heritable phenotypic variation, but that epigenetic changes also play an important role in the variation of predisposition to disease and to drug response. In this review, we discuss recent evidence of epigenetic changes that play an important role in the development of cardiac hypertrophy and heart failure and may dictate response to therapy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • DNA Methylation
  • Epigenesis, Genetic*
  • Genetic Predisposition to Disease*
  • Heart Failure / genetics*
  • Humans
  • MicroRNAs / genetics
  • Pharmacogenetics*

Substances

  • MicroRNAs